WELCOME
- Hospital
- Kesavadev Trust
- Type 1
- Dreams
- Gems
- JPEF
- Clinical Research
- Publications
- Courses
- Knowledge Library
- WDD
- DTMS
- Facilities
- Services
- Team
Diabscreen Kerala is a major diabetes awareness project of P.Kesavadev Trust. The Diabscreen Kerala team, headed by Dr. Jothydev Kesavadev, conducts diabetes awareness, prevention, and treatment programs at various geographical locations in collaboration with regional organizations.
An initiative by P.Kesavadev Trust.
The SOUL Trial, presented at the ACC 2025, showed that oral semaglutide (Rybelsus) reduced major heart-related events by 14% in people with type 2 diabetes and heart or kidney disease.
Dr. Jothydev Kesavadev congratulated the research team and shared a video explaining the results and their importance for the Asian population.